MDS1 and EVI1 Complex Locus Protein
"MDS1 and EVI1 Complex Locus Protein" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A DNA binding protein, transcriptional regulator, and proto-oncogene protein that contains 10 CYS2-HIS2 ZINC FINGERS. It functions as a positive or negative regulator of expression for target genes involved in organism development.
| Descriptor ID |
D000074008
|
| MeSH Number(s) |
D12.776.260.534 D12.776.624.664.700.129 D12.776.930.419
|
| Concept/Terms |
MDS1 and EVI1 Complex Locus Protein- MDS1 and EVI1 Complex Locus Protein
- Ecotropic Virus Integration Site 1 Protein Homolog
- Zinc Finger Protein Evi1
- MECOM Protein
- Myelodysplasia Syndrome-Associated Protein 1
- Myelodysplasia Syndrome Associated Protein 1
|
Below are MeSH descriptors whose meaning is more general than "MDS1 and EVI1 Complex Locus Protein".
Below are MeSH descriptors whose meaning is more specific than "MDS1 and EVI1 Complex Locus Protein".
This graph shows the total number of publications written about "MDS1 and EVI1 Complex Locus Protein" by people in this website by year, and whether "MDS1 and EVI1 Complex Locus Protein" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 2 | 2 |
| 2002 | 0 | 5 | 5 |
| 2003 | 0 | 4 | 4 |
| 2004 | 0 | 3 | 3 |
| 2005 | 0 | 6 | 6 |
| 2006 | 0 | 6 | 6 |
| 2007 | 0 | 3 | 3 |
| 2008 | 0 | 11 | 11 |
| 2009 | 0 | 1 | 1 |
| 2010 | 0 | 11 | 11 |
| 2011 | 0 | 11 | 11 |
| 2012 | 0 | 8 | 8 |
| 2013 | 0 | 11 | 11 |
| 2014 | 0 | 9 | 9 |
| 2015 | 0 | 7 | 7 |
| 2016 | 3 | 5 | 8 |
| 2017 | 3 | 9 | 12 |
| 2018 | 14 | 4 | 18 |
| 2019 | 3 | 1 | 4 |
| 2020 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "MDS1 and EVI1 Complex Locus Protein" by people in Profiles.
-
EVI1 induces autophagy to promote drug resistance via regulation of ATG7 expression in leukemia cells. Carcinogenesis. 2020 07 14; 41(7):961-971.
-
Prognostic significance of the EVI1 gene expression in patients with acute myeloid leukemia: a meta-analysis. Ann Hematol. 2019 Nov; 98(11):2485-2496.
-
Chronic otitis media is initiated by a bulla cavitation defect in the FBXO11 mouse model. Dis Model Mech. 2019 03 21; 12(3).
-
A critical role of epigenetic inactivation of miR-9 in EVI1high pediatric AML. Mol Cancer. 2019 02 27; 18(1):30.
-
EVI1 promotes epithelial-to-mesenchymal transition, cancer stem cell features and chemo-/radioresistance in nasopharyngeal carcinoma. J Exp Clin Cancer Res. 2019 Feb 15; 38(1):82.
-
EVI-1 acts as an oncogene and positively regulates calreticulin in breast cancer. Mol Med Rep. 2019 Mar; 19(3):1645-1653.
-
Molecular characterization of ABHD5 gene promoter in intramuscular preadipocytes of Qinchuan cattle: Roles of Evi1 and C/EBPa. Gene. 2019 Mar 30; 690:38-47.
-
Coexpression of ETV6/MDS1/EVI1 and ETV6/EVI1 fusion transcripts in acute myeloid leukemia with t(3;12)(q26.2;p13) and thrombocytosis. Leuk Lymphoma. 2019 05; 60(5):1294-1298.
-
Creatine kinase pathway inhibition alters GSK3 and WNT signaling in EVI1-positive AML. Leukemia. 2019 03; 33(3):800-804.
-
EVI1 overexpression reprograms hematopoiesis via upregulation of Spi1 transcription. Nat Commun. 2018 10 12; 9(1):4239.